Doctors who treat patients for obesity say help is needed to improve access
Key genes like GLP1R, GIPR, FTO, and MC4R influence your peptide sensitivity, hunger hormones, and metabolic ratefactors that determine whether you'll thrive on semaglutide, tirzepatide, or a combination approach
If symptoms persist, discuss a short course of a proton pump inhibitor (PPI) with your GP or pharmacist
Community Insights Self-reported by pep-pedia.org users
Recent advances have also shown that GLP-1 agonists can be beneficial for weight management, as they slow stomach emptying and increase feelings of fullness, which often leads to reduced calorie intake
The drug performed better on all secondary endpoints as well, including a greater percentage of people losing at least 15% of their weight (roughly a third of those on the highest dose achieved this)